Yahoo Web Search

Search results

    • Tempus launches new HER2 and FOLR1 testing solutions

      Tempus launches new HER2 and FOLR1 testing solutions

      Medical Device Network via Yahoo Finance· 6 days ago

      Tempus oncology chief medical officer Ezra Cohen said: “Expanding our offerings to include tests for specific, predictive biomarkers, like HER2, can help...